封面
市場調查報告書
商品編碼
1612820

帶因者篩檢市場:按類型、病理學、技術、最終用戶分類 - 2025-2030 年全球預測

Carrier Screening Market by Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), Medical Condition (Hematological Conditions, Neurological Conditions, Pulmonary Conditions), Technology, End-User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年,帶因者篩檢市場價值為30.7億美元,預計到2024年將達到35.2億美元,複合年成長率為14.93%,預計到2030年將達到81.3億美元。

攜帶者篩檢是一種基因檢測方法,用於確定個體是否是可遺傳給後代的特定基因突變的攜帶者。它可以識別體染色體隱性遺傳和 X 連鎖疾病的攜帶者,並為計劃生育提供重要資訊。攜帶者篩檢的必要性源自於預防遺傳疾病傳播的可能性,使其成為預防醫學和生殖計畫的重要工具。它可以幫助準父母在受孕前和產前情況下做出明智的生殖選擇。最終用途主要是醫院、診斷實驗室和私人診所。

主要市場統計
基準年[2023] 30.7億美元
預測年份 [2024] 35.2億美元
預測年份 [2030] 81.3億美元
複合年成長率(%) 14.93%

帶因者篩檢市場主要是由人們對遺傳疾病的認知不斷提高、基因檢測技術的進步以及遺傳患者病率上升所推動的。關鍵的成長要素包括次世代定序(NGS) 技術的整合,該技術可提供更廣泛、更準確的遺傳變異分析。遠端醫療和家庭檢測套組的擴展提供了新的機遇,為用戶提供了更廣泛的存取和便利。為了利用這些機會,公司應該考慮投資策略聯盟並提高測試的成本效率。

然而,市場面臨測試成本上升、道德考量和監管挑戰等限制。假陽性和假陰性的可能性可能會造成意想不到的道德困境並影響市場成長。此外,接收測試結果和接受遺傳諮詢的需要增加了複雜性和成本。為了促進創新,重要的是要專注於開發更便宜的篩檢技術,提高測試準確性,並增強鼓勵消費者參與的使用者友善介面。基因治療和編輯技術CRISPR的研究也可能為未來的成長提供一條道路。攜帶者篩檢市場的本質是動態和不斷發展的,其特點是技術的快速進步和監管的開拓。投資於患者教育計劃以提高潛在用戶的認知和接受度可以促進業務成長。

市場動態:揭示快速發展的職業篩檢市場的關鍵市場洞察

供需的動態交互作用正在改變職業篩檢市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 遺傳病患病率上升,注重早期發現與預防
    • 老年人口增加,染色體異常風險高
    • 增加對衛生基礎設施的投資和政府管理遺傳疾病的努力
  • 市場限制因素
    • 缺乏熟練的專業人員和專業服務
  • 市場機會
    • POC診斷的新改進
    • 攜帶者篩檢的技術進步
  • 市場問題
    • 存在不統一的標準和指南

波特的五力:駕馭職業篩檢市場的策略工具

波特的五力架構是了解職業篩檢市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點,避免潛在的挑戰,確保更強大的市場地位。

PESTLE分析:了解職業篩檢市場的外部影響

外部宏觀環境因素在塑造職業篩檢市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並為他們做出積極主動的決策做好準備。

市場佔有率分析:了解職業篩檢市場的競爭格局

職業篩檢市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣:營運商篩檢市場供應商績效評估

FPNV定位矩陣是評估營運商篩檢市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議:規劃職涯篩檢市場的成功之路

職業篩檢市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰,利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率:對當前市場環境的詳細審查,主要企業的廣泛資料,評估他們在市場中的影響力和整體影響力。

2. 市場開拓:辨識新興市場的成長機會,評估現有細分市場的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品和地區提供最佳投資機會?

3.塑造市場的關鍵技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 遺傳性疾病增加,重視早期發現與預防
      • 人口老化加劇和染色體異常的高風險
      • 增加對衛生基礎設施的投資和政府管理遺傳疾病的舉措
    • 抑制因素
      • 缺乏熟練的專業人員和專業服務
    • 機會
      • POC診斷的新改進
      • 攜帶者篩檢的技術進步
    • 任務
      • 存在不統一的標準和指南
  • 市場區隔分析
    • 類型:擴展攜帶者篩檢(ECS) 提供遺傳健康和狀況的廣泛概述
    • 最終使用者:醫院攜帶者篩檢應用的演變
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章職業篩檢市場:依類型

  • 介紹
  • 擴大攜帶者篩檢
    • 客製化面板測試
    • 預先設計的面板測試
  • 目標疾病攜帶者篩檢

第7章 帶因者篩檢市場:依醫療狀況分類

  • 介紹
  • 血液疾病
  • 神經系統疾病
  • 肺部疾病

第8章職業篩檢市場:依技術分類

  • 介紹
  • DNA序列分析
  • 微陣列
  • 聚合酵素鏈鎖反應

第9章職業篩檢市場:依最終使用者分類

  • 介紹
  • 醫院
  • 醫生辦公室和診所
  • 參考實驗室

第10章 美洲業者篩檢市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太職業篩檢市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的職業篩檢市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
    • Invitae 完成向 Natera 出售生殖健康資產
    • Fulgent Genetics 宣布推出新的 Beacon787 擴展帶因者篩檢小組
    • Bio-Techne 和 Oxford Nanopore Technologies 合作將創新的生殖醫學和帶因者篩檢解決方案推向市場
  • 戰略分析和建議

公司名單

  • 23Andme Inc.
  • Abbott Laboratories
  • Ambry Genetics Corporation by Konica Minolta, Inc.
  • Asper Biogene
  • Autogenomics Inc. by Prescient Medicine Holdings Inc.
  • BGI Genomics Co., Ltd.
  • Biora Therapeutics, Inc.
  • CENTOGENE NV
  • Danaher Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Fulgent Genetics, Inc.
  • Gene by Gene, Ltd. by myDNA Inc.
  • GeneDx Holdings Corp.
  • Illumina Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Luminex Corporation by DiaSorin Company
  • MedGenome Labs Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • OPKO Health, Inc.
  • Otogenetics Corporation
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • TRUE HEALTH LABS
Product Code: MRR-034230D3E2DE

The Carrier Screening Market was valued at USD 3.07 billion in 2023, expected to reach USD 3.52 billion in 2024, and is projected to grow at a CAGR of 14.93%, to USD 8.13 billion by 2030.

Carrier screening is a genetic testing procedure used to determine if an individual is a carrier of a specific genetic mutation that could potentially be passed on to their offspring. Its scope extends to identifying carriers of autosomal recessive and X-linked genetic disorders, providing vital information for family planning. The necessity of carrier screening arises from its potential to prevent the transmission of genetic disorders, making it an essential tool in preventive healthcare and reproductive planning. It finds applications in pre-pregnancy and prenatal contexts, aiding prospective parents in making informed reproductive choices. The end-use scope primarily involves hospitals, diagnostic laboratories, and private clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 3.07 billion
Estimated Year [2024] USD 3.52 billion
Forecast Year [2030] USD 8.13 billion
CAGR (%) 14.93%

The market for carrier screening is primarily driven by increasing awareness of genetic disorders, advancements in genetic testing technologies, and the rising prevalence of genetic conditions. Key growth factors include the integration of next-generation sequencing (NGS) technologies that offer a broader and more accurate analysis of genetic mutations. The expansion of telehealth and at-home testing kits provides new opportunities, enabling wider accessibility and convenience for users. Companies should consider investing in strategic collaborations and improving the cost-efficiency of tests to tap into these opportunities.

However, the market faces limitations such as high costs of testing, ethical considerations, and regulatory challenges. The potential of false positives or negatives can result in unforeseen ethical dilemmas, impacting market growth. Moreover, the need for genetic counseling following test results adds to the complexity and cost. To foster innovation, focusing on developing more affordable screening technologies, improving test accuracy, and enhancing user-friendly interfaces for consumer engagement is crucial. Researching into gene therapy and editing techniques CRISPR could also provide pathways for future growth. The nature of the carrier screening market is dynamic and evolving, characterized by rapid technological advancements and regulatory developments. Business growth can be bolstered by investing in patient education initiatives to enhance awareness and acceptance among potential users.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Carrier Screening Market

The Carrier Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of inherited diseases and focus on early disease detection and prevention
    • Rising geriatric population and high risk of chromosomal abnormalities
    • Increasing investment in healthcare infrastructure and government initiatives for the management of genetic disorders
  • Market Restraints
    • Dearth of skilled professionals and professional services
  • Market Opportunities
    • Emerging improvements in POC diagnostics
    • Technological advancements in carrier screening
  • Market Challenges
    • Presence of non-uniform standards and guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Carrier Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Carrier Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Carrier Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Carrier Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Carrier Screening Market

A detailed market share analysis in the Carrier Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Carrier Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Carrier Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Carrier Screening Market

A strategic analysis of the Carrier Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Carrier Screening Market, highlighting leading vendors and their innovative profiles. These include 23Andme Inc., Abbott Laboratories, Ambry Genetics Corporation by Konica Minolta, Inc., Asper Biogene, Autogenomics Inc. by Prescient Medicine Holdings Inc., BGI Genomics Co., Ltd., Biora Therapeutics, Inc., CENTOGENE N.V., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Gene by Gene, Ltd. by myDNA Inc., GeneDx Holdings Corp., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation by DiaSorin Company, MedGenome Labs Ltd., Myriad Genetics, Inc., Natera, Inc., OPKO Health, Inc., Otogenetics Corporation, Quest Diagnostics Inc., Thermo Fisher Scientific Inc., and TRUE HEALTH LABS.

Market Segmentation & Coverage

This research report categorizes the Carrier Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Expanded Carrier Screening and Targeted Disease Carrier Screening. The Expanded Carrier Screening is further studied across Customized Panel Testing and Predesigned Panel Testing.
  • Based on Medical Condition, market is studied across Hematological Conditions, Neurological Conditions, and Pulmonary Conditions.
  • Based on Technology, market is studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction.
  • Based on End-User, market is studied across Hospitals, Physician Offices & Clinics, and Reference Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of inherited diseases and focus on early disease detection and prevention
      • 5.1.1.2. Rising geriatric population and high risk of chromosomal abnormalities
      • 5.1.1.3. Increasing investment in healthcare infrastructure and government initiatives for the management of genetic disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of skilled professionals and professional services
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging improvements in POC diagnostics
      • 5.1.3.2. Technological advancements in carrier screening
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of non-uniform standards and guidelines
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanded carrier screening (ECS) offers a wide overview of genetic health and conditions
    • 5.2.2. End-User: Evolving application of carrier screening in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Carrier Screening Market, by Type

  • 6.1. Introduction
  • 6.2. Expanded Carrier Screening
    • 6.2.1. Customized Panel Testing
    • 6.2.2. Predesigned Panel Testing
  • 6.3. Targeted Disease Carrier Screening

7. Carrier Screening Market, by Medical Condition

  • 7.1. Introduction
  • 7.2. Hematological Conditions
  • 7.3. Neurological Conditions
  • 7.4. Pulmonary Conditions

8. Carrier Screening Market, by Technology

  • 8.1. Introduction
  • 8.2. DNA Sequencing
  • 8.3. Microarrays
  • 8.4. Polymerase Chain Reaction

9. Carrier Screening Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Physician Offices & Clinics
  • 9.4. Reference Laboratories

10. Americas Carrier Screening Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Carrier Screening Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Carrier Screening Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Invitae Completes Sale of Reproductive Health Assets to Natera
    • 13.3.2. Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
    • 13.3.3. Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 23Andme Inc.
  • 2. Abbott Laboratories
  • 3. Ambry Genetics Corporation by Konica Minolta, Inc.
  • 4. Asper Biogene
  • 5. Autogenomics Inc. by Prescient Medicine Holdings Inc.
  • 6. BGI Genomics Co., Ltd.
  • 7. Biora Therapeutics, Inc.
  • 8. CENTOGENE N.V.
  • 9. Danaher Corporation
  • 10. Eurofins Scientific
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Fulgent Genetics, Inc.
  • 13. Gene by Gene, Ltd. by myDNA Inc.
  • 14. GeneDx Holdings Corp.
  • 15. Illumina Inc.
  • 16. Invitae Corporation
  • 17. Laboratory Corporation of America Holdings
  • 18. Luminex Corporation by DiaSorin Company
  • 19. MedGenome Labs Ltd.
  • 20. Myriad Genetics, Inc.
  • 21. Natera, Inc.
  • 22. OPKO Health, Inc.
  • 23. Otogenetics Corporation
  • 24. Quest Diagnostics Inc.
  • 25. Thermo Fisher Scientific Inc.
  • 26. TRUE HEALTH LABS

LIST OF FIGURES

  • FIGURE 1. CARRIER SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. CARRIER SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARRIER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CARRIER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CARRIER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARRIER SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARRIER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARRIER SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARRIER SCREENING MARKET SIZE, BY CUSTOMIZED PANEL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARRIER SCREENING MARKET SIZE, BY PREDESIGNED PANEL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARRIER SCREENING MARKET SIZE, BY TARGETED DISEASE CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARRIER SCREENING MARKET SIZE, BY HEMATOLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARRIER SCREENING MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARRIER SCREENING MARKET SIZE, BY PULMONARY CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARRIER SCREENING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARRIER SCREENING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARRIER SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARRIER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARRIER SCREENING MARKET SIZE, BY PHYSICIAN OFFICES & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARRIER SCREENING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. CARRIER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. CARRIER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023